Alesta Therapeutics
Netherlands
activeseries-a
series-a
Stage
2020
Founded
1
Investors
About
Alesta Therapeutics is a biotechnology company focused on developing transformative small-molecule therapies for rare diseases. Its lead program, ALE1, is designed to treat hypophosphatasia, a rare genetic disorder, and is currently in clinical development.
Explore Alesta Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.